
VA ACO Public Reporting
ACO Name and Location:
UVA Community Health Accountable Care Organization, LLC
28 Blackwell Park Lane, Suite 303
Warrenton, VA 20186
ACO Primary Contact:
James Min, MD, ACO Executive
703-559-1403
Organizational Information:
ACO Participants:
ACO Participants | ACO Participant in Joint Venture |
---|---|
NMG Affiliate Practice I, LLC | N |
Piedmont Family Practice, PLC | N |
ACO Governing Body:
Member Last Name | Member First Name | Member Title/Position | Member's Voting Power (Expressed as a percentage or number) | Membership Type | ACO Participant Legal Business Name and D/B/A, if applicable |
---|---|---|---|---|---|
Von Elton, MD | Steve | Chair, Voting Member | 1 | ACO Participant | Piedmont Family Practice, PLC |
Siford, MD | Kara | Vice Chair, Voting Member | 1 | ACO Participant | NMG Affiliate Practice I, LLC |
DeRosa, MD | Gary | Voting Member | 1 | ACO Participant | NMG Affiliate Practice I, LLC |
Ward, MD | Chris | Voting Member | 1 | ACO Participant | Piedmont Family Practice, PLC |
Heaton, MD | Chris | Voting Member | 1 | ACO Participant | NMG Affiliate Practice I, LLC |
Hammonds, MD | Victoria | Voting Member | 1 | ACO Participant | NMG Affiliate Practice I, LLC |
Grzejka | John | Voting Member | 1 | Medicare Beneficiary | N/A |
Kumar | Devipreya | Voting Member | 1 | Non_ACO Participant Representative | N/A |
Key ACO Clinical and Administrative Leadership:
ACO Executive: James Min, MD
Medical Director: Kara Siford, MD
Compliance Officer: Patricia Slater
Quality Assurance/Improvement Officer: Michelle Strider
Associated Committees and Committee Leadership:
Committee Name | Committee Leader Name and Position |
---|---|
ACO Quality Committee | Chair: Michelle Strider |
Types of ACO Participants, or Combinations of Participants, That Formed the ACO:
- ACO professionals in a group practice arrangement
Shared Savings and Losses
Amount of Shared Savings and Losses:
- Second Agreement Period
- Performance Year 2020, $803,751.14
- First Agreement Period
- Performance Year 2019, $2,443,666.80
- Performance Year 2018, $0
- Performance Year 2017, $0
Shared Savings Distribution:
- Second Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: 47%
- Proportion invested in redesigned care processes/resources: 37%
- Proportion of distribution to ACO participants: 16%
- Performance Year 2020
- First Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 9%
- Proportion invested in redesigned care processes/resources: 53%
- Proportion of distribution to ACO participants: 38%
- Performance Year 2019
- Performance Year 2018
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2017
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
Quality Performance Results:
2020 Quality Performance Results:
ACO # | Measure Name | Rate | ACO Mean |
---|---|---|---|
ACO-43 | Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) | 0.97 | 0.95 |
ACO-13 | Falls: Screening for Future Fall Risk | 85.60 | 84.97 |
ACO-14 | Preventive Care and Screening: Influenza Immunization | 77.27 | 76.03 |
ACO-17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 66.67 | 81.67 |
ACO-18 | Preventive Care and Screening: Screening for Depression and Follow-up Plan | 89.42 | 71.46 |
ACO-19 | Colorectal Cancer Screening | 77.89 | 72.59 |
ACO-20 | Breast Cancer Screening | 72.82 | 74.05 |
ACO-42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 90.66 | 83.37 |
ACO-27 | Diabetes Mellitus: Hemoglobin A1c Poor Control | 9.92 | 14.70 |
ACO-28 | Hypertension (HTN): Controlling High Blood Pressure | 71.32 | 72.87 |
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey data for PY 2020 though the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporrting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.
For Previous Years' Quality Performance Results please visit: data.cms.gov